Quick Answer
GoodRx Holdings, Inc. reported Total Revenue of $796.85 million for fiscal year 2025.
GoodRx Holdings, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $796.85M | +0.6% |
| 2024 | $792.32M | +5.6% |
| 2023 | $750.26M | -2.1% |
| 2022 | $766.55M | +2.8% |
| 2021 | $745.42M | +35.4% |
| 2020 | $550.70M | +41.9% |
| 2019 | $388.22M | +55.6% |
| 2018 | $249.52M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $196.03M | +0.4% | -3.5% |
| June 30, 2025 | $203.07M | +1.2% | +0.0% |
| March 31, 2025 | $202.97M | +2.6% | +4.0% |
| September 30, 2024 | $195.25M | +8.5% | -2.7% |
| June 30, 2024 | $200.61M | +5.8% | +1.4% |
| March 31, 2024 | $197.88M | +7.6% | +10.0% |
| September 30, 2023 | $179.96M | -3.9% | -5.1% |
| June 30, 2023 | $189.68M | -1.1% | +3.1% |
- GoodRx Holdings, Inc. showed an increase of +0.6% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2025 period, GoodRx Holdings, Inc.’s total revenue has grown by 219.4% (from $249.52 million to $796.85 million).
- The most recent figure is from GoodRx Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: